Sanjay S. Shukla
2023
In 2023, Sanjay S. Shukla earned a total compensation of $1.3M as President and CEO at aTYR PHARMA, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,435 |
|---|---|
| Option Awards | $532,341 |
| Salary | $561,243 |
| Other | $10,506 |
| Total | $1,300,525 |
Shukla received $561.2K in salary, accounting for 43% of the total pay in 2023.
Shukla also received $196.4K in non-equity incentive plan, $532.3K in option awards and $10.5K in other compensation.
Rankings
In 2023, Sanjay S. Shukla's compensation ranked 931st out of 3,006 executives tracked by ExecPay. In other words, Shukla earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 931 out of 3,006 | 69th |
Division Manufacturing | 549 out of 1,650 | 67th |
Major group Chemicals And Allied Products | 373 out of 918 | 59th |
Industry group Drugs | 362 out of 881 | 59th |
Industry Biological Products, Except Diagnostic Substances | 110 out of 213 | 48th |
Source: SEC filing on April 5, 2024.
Shukla's colleagues
We found two more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2023.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019